NewslettersCell Therapy NewsHematopoiesis News Genetic Correction of Haemoglobin E in an Immortalised Haemoglobin E/Beta-Thalassaemia Cell Line Using the CRISPR/Cas9 System By Bob - September 19, 2022 0 Scientists reported a highly efficient genetic correction of haemoglobin E mutation in the immortalised erythroid cell line cells using the CRISPR/Cas9 system. [Scientific Reports] Full Article